SEC Form 4 · accession 0000905148-17-000616
Athenex, Inc. · ATNX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Rudolf Kwan
Officer — EVP, Chief Medical Officer · Director
Period of report
Jun 19, 2017
Accepted (ET)
Jun 21, 2017 · 3:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001300699
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $11.00 | Jun 19, 2017 | A | 140,000 | A | — | Jun 19, 2027 | Common Stock | 140,000 | 140,000 | D |
Explanation of responses
- F1The option vests in three equal annual installments beginning on June 19, 2017.
Remarks
Exhibit List: The Power of Attorney filed as 24.1 to the Form 3 filed by the Reporting Person on June 13, 2017 is incorporated herein by reference.